Cumulative South Carolina Antibiogram Project Frequently Asked Questions
- How long will the survey take me to complete?
The survey should take approximately 20-30 minutes to complete.
- Who is best suited to complete the survey?
Although the initial point-of-contacts for your institution are the ICPs and
director of pharmacy, they may not be the most appropriate personnel to
complete the survey. The person completing the survey at each institution
must have intimate knowledge of antibiogram development. This may
require a collaborative effort at some institutions.
- Is Institutional Review Board (IRB) approval required for participation
in this project?
No. Patient-level information is not included in this aggregate data set.
- Does my Antibiogram submission need to be formatted exactly as the
No. Various formats will be accepted, including finalized reports as well
as raw data. If clarification is needed, a member of the investigative team
will contact you. Most electronic file formats are acceptable (.doc, .xls,
.pdf, .tif, etc).
- What if my institution does not have complete data for a year?
We understand that this may be the case, and will excitedly accept all
data available from your institution.
- Can the survey be completed at a separate time from when antibiogram
data is submitted?
Yes. As long as both items are returned within the timeline on the
information page, survey completion and data submission do not need to
be completed concurrently or in any specific order.
- What is the timeline for survey completion and antibiogram data
We anticipate a rolling submission of data, given participation from over
60 institutions within the state. We prefer to receive the data as soon as
it can be provided. However, the deadline for submission of both the
survey and antibiogram data will be September 30, 2012.
- What does the future hold for this project?
After this initial data collection, we aim to begin completing a similar
submission process annually. We also hope through this process, we may
facilitate the development of institution- and region-specific resistance
benchmarks, antibiogram guide programs and antimicrobial stewardship